v3.26.3
Consolidated statements of income - EUR (€)
€ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Revenue:        
Healthcare services € 3,312,626 € 3,219,669 € 9,709,307 € 9,721,334
Healthcare products 1,120,332 1,097,603 3,230,973 3,277,466
Insurance contracts 503,784 567,578 1,469,175 1,559,217
Revenue 4,936,742 4,884,850 14,409,455 14,558,017
Costs of revenue:        
Healthcare services 2,556,607 2,478,060 7,528,064 7,642,514
Healthcare products 606,594 601,258 1,701,655 1,758,380
Insurance contracts 498,168 563,314 1,414,889 1,516,566
Costs of revenue 3,661,369 3,642,632 10,644,608 10,917,460
Operating (income) expenses:        
Selling, general and administrative 743,603 705,440 2,228,553 2,248,105
Research and development 41,398 37,748 119,337 119,346
(Income) loss from equity method investees (18,162) (46,672) (18,228) (139,680)
Other operating income (116,365) (56,077) (394,756) (397,236)
Other operating expense 240,810 125,274 693,802 576,844
Operating income 384,089 476,505 1,136,139 1,233,178
Other (income) expense:        
Interest income (16,046) (19,159) (45,365) (55,989)
Interest expense 97,505 93,096 288,359 285,392
Income before income taxes 302,630 402,568 893,145 1,003,775
Income tax expense 77,835 75,225 210,417 214,528
Net income 224,795 327,343 682,728 789,247
Net income attributable to noncontrolling interests 65,018 52,546 187,045 137,958
Net income attributable to shareholders of FME AG € 159,777 € 274,797 € 495,683 € 651,289
Basic earnings per share € 0.61 € 0.94 € 1.84 € 2.22
Diluted earnings per share € 0.61 € 0.94 € 1.84 € 2.22